436 related articles for article (PubMed ID: 28755240)
1. Bridging to liver transplantation in HCC patients.
Kollmann D; Selzner N; Selzner M
Langenbecks Arch Surg; 2017 Sep; 402(6):863-871. PubMed ID: 28755240
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcomes of hepatocellular carcinoma that underwent chemoembolization for bridging or downstaging.
Affonso BB; Galastri FL; da Motta Leal Filho JM; Nasser F; Falsarella PM; Cavalcante RN; de Almeida MD; Felga GEG; Valle LGM; Wolosker N
World J Gastroenterol; 2019 Oct; 25(37):5687-5701. PubMed ID: 31602168
[TBL] [Abstract][Full Text] [Related]
3. Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta-analysis.
Kulik L; Heimbach JK; Zaiem F; Almasri J; Prokop LJ; Wang Z; Murad MH; Mohammed K
Hepatology; 2018 Jan; 67(1):381-400. PubMed ID: 28859222
[TBL] [Abstract][Full Text] [Related]
4. Safety of transarterial chemoembolization as bridging therapy in HCC patients with hyperbilirubinemia on the waiting list for liver transplantation: a centre experience.
Thorat A; Lee CF; Wu TH; Chan KM; Chou HS; Lee WC
Hepatogastroenterology; 2013; 60(128):2076-9. PubMed ID: 24719950
[TBL] [Abstract][Full Text] [Related]
5. Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation.
Pompili M; Francica G; Ponziani FR; Iezzi R; Avolio AW
World J Gastroenterol; 2013 Nov; 19(43):7515-30. PubMed ID: 24282343
[TBL] [Abstract][Full Text] [Related]
6. Impact of neo-adjuvant Sorafenib treatment on liver transplantation in HCC patients - a prospective, randomized, double-blind, phase III trial.
Hoffmann K; Ganten T; Gotthardtp D; Radeleff B; Settmacher U; Kollmar O; Nadalin S; Karapanagiotou-Schenkel I; von Kalle C; Jäger D; Büchler MW; Schemmer P
BMC Cancer; 2015 May; 15():392. PubMed ID: 25957784
[TBL] [Abstract][Full Text] [Related]
7. Radiofrequency ablation of hepatocellular carcinoma as bridge therapy to liver transplantation: A 10-year intention-to-treat analysis.
Lee MW; Raman SS; Asvadi NH; Siripongsakun S; Hicks RM; Chen J; Worakitsitisatorn A; McWilliams J; Tong MJ; Finn RS; Agopian VG; Busuttil RW; Lu DSK
Hepatology; 2017 Jun; 65(6):1979-1990. PubMed ID: 28170115
[TBL] [Abstract][Full Text] [Related]
8. Pre-transplant treatment of hepatocellular carcinoma: assessment of tumor necrosis in explanted livers.
Wong LL; Tanaka K; Lau L; Komura S
Clin Transplant; 2004 Jun; 18(3):227-34. PubMed ID: 15142041
[TBL] [Abstract][Full Text] [Related]
9. Current Standard and Future Perspectives in Non-Surgical Therapy for Hepatocellular Carcinoma.
Eggert T; Greten TF
Digestion; 2017; 96(1):1-4. PubMed ID: 28605745
[TBL] [Abstract][Full Text] [Related]
10. Treatment before liver transplantation for HCC.
Belghiti J; Carr BI; Greig PD; Lencioni R; Poon RT
Ann Surg Oncol; 2008 Apr; 15(4):993-1000. PubMed ID: 18236111
[TBL] [Abstract][Full Text] [Related]
11. Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma.
Decaens T; Roudot-Thoraval F; Bresson-Hadni S; Meyer C; Gugenheim J; Durand F; Bernard PH; Boillot O; Boudjema K; Calmus Y; Hardwigsen J; Ducerf C; Pageaux GP; Dharancy S; Chazouilleres O; Dhumeaux D; Cherqui D; Duvoux C
Liver Transpl; 2005 Jul; 11(7):767-775. PubMed ID: 15973710
[TBL] [Abstract][Full Text] [Related]
12. Disease course after liver transplantation for hepatocellular carcinoma in patients with complete tumor necrosis in liver explants after performance of bridging treatments.
Sotiropoulos GC; Malago M; Molmenti EP; Radtke A; Brokalaki EI; Nadalin S; Lang H; Frilling A; Baba HA; Kühl H; Verhagen R; Broelsch CE
Eur J Med Res; 2005 Dec; 10(12):539-42. PubMed ID: 16356871
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic body radiotherapy vs. TACE or RFA as a bridge to transplant in patients with hepatocellular carcinoma. An intention-to-treat analysis.
Sapisochin G; Barry A; Doherty M; Fischer S; Goldaracena N; Rosales R; Russo M; Beecroft R; Ghanekar A; Bhat M; Brierley J; Greig PD; Knox JJ; Dawson LA; Grant DR
J Hepatol; 2017 Jul; 67(1):92-99. PubMed ID: 28257902
[TBL] [Abstract][Full Text] [Related]
14. Liver transplantation for hepatocellular carcinoma.
Taketomi A; Soejima Y; Yoshizumi T; Uchiyama H; Yamashita Y; Maehara Y
J Hepatobiliary Pancreat Surg; 2008; 15(2):124-30. PubMed ID: 18392704
[TBL] [Abstract][Full Text] [Related]
15. Transarterial chemoembolization for HCC in patients with extensive liver transplantation waiting times.
Eswaran SL; Pierce K; Weaver F; Rogers T; Brems JJ; Sontag SJ; Borge M
Angiology; 2012 Apr; 63(3):206-12. PubMed ID: 21733955
[TBL] [Abstract][Full Text] [Related]
16. Transarterial Chemoembolization Prior to Liver Transplantation in Patients with Hepatocellular Carcinoma.
Hołówko W; Wróblewski T; Wojtaszek M; Grąt M; Kobryń K; Ziarkiewicz-Wróblewska B; Krawczyk M
Ann Transplant; 2015 Dec; 20():764-8. PubMed ID: 26712800
[TBL] [Abstract][Full Text] [Related]
17. The Intention-to-Treat Effect of Bridging Treatments in the Setting of Milan Criteria-In Patients Waiting for Liver Transplantation.
Lai Q; Vitale A; Iesari S; Finkenstedt A; Mennini G; Onali S; Hoppe-Lotichius M; Manzia TM; Nicolini D; Avolio AW; Mrzljak A; Kocman B; Agnes S; Vivarelli M; Tisone G; Otto G; Tsochatzis E; Rossi M; Viveiros A; Ciccarelli O; Cillo U; Lerut J;
Liver Transpl; 2019 Jul; 25(7):1023-1033. PubMed ID: 31087772
[TBL] [Abstract][Full Text] [Related]
18. Multimodality treatment for early-stage hepatocellular carcinoma: a bridging therapy for liver transplantation.
Ashoori N; Bamberg F; Paprottka P; Rentsch M; Kolligs FT; Siegert S; Peporte A; Al-Tubaikh JA; D'Anastasi M; Hoffmann RT; Reiser MF; Jakobs TF
Digestion; 2012; 86(4):338-48. PubMed ID: 23207185
[TBL] [Abstract][Full Text] [Related]
19. Radiofrequency ablation and transarterial chemoembolisation as first-line treatment for recurrent hepatocellular carcinoma or isolated intrahepatic recurrent hepatocellular carcinoma in transplanted livers.
Kim SS; Kang TW; Song KD; Cho SK; Lee MW; Rhim H; Sinn DH; Jung SH
Clin Radiol; 2017 Feb; 72(2):141-149. PubMed ID: 27742104
[TBL] [Abstract][Full Text] [Related]
20. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome.
Graziadei IW; Sandmueller H; Waldenberger P; Koenigsrainer A; Nachbaur K; Jaschke W; Margreiter R; Vogel W
Liver Transpl; 2003 Jun; 9(6):557-63. PubMed ID: 12783395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
